As of 2025-09-15, the Intrinsic Value of Biophytis SA (ALBPS.PA) is -2.25 EUR. This ALBPS.PA valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.17 EUR, the upside of Biophytis SA is -1,404.85%.
Based on its market price of 0.17 EUR and our intrinsic valuation, Biophytis SA (ALBPS.PA) is overvalued by 1,404.85%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -2.25 - -2.25 | -2.25 | -1,404.85% |
| P/E | (1.88) - (2.73) | (1.99) | -1253.5% |
| DDM - Stable | (2.05) - (5.90) | (3.98) | -2401.8% |
| DDM - Multi | (1.54) - (3.77) | (2.22) | -1387.5% |
| Market Cap (mil) | 4.05 |
| Beta | -0.11 |
| Outstanding shares (mil) | 23.43 |
| Enterprise Value (mil) | 11.53 |
| Market risk premium | 5.82% |
| Cost of Equity | 14.92% |
| Cost of Debt | 5.00% |
| WACC | 7.81% |